Section 521.1.1. Recommendation for fiscal year 1999-2000.


Latest version.
  • The livestock health advisory council recommends that this appropriation for fiscal year 1999-2000 be applied in the following manner.

    ILHAC Projects Approved for 1999-2000

    1.

    The role of immediate hypersensitivity in Haemophilus somnus-induced bovine respiratory disease

    $20,000

    2.

    Investigation into the prevalence of H3N2 swine influenza virus infections in U.S. swine

    $20,000

    3.

    Specific effect of PrP scrapie on types of brain cells

    $15,000

    4.

    Gene discovery in veterinary mycoplasmal pathogens

    $20,000

    5.

    Antigenic characterization of PRRS virus isolates associated with acute PRRS and vaccination failure

    $20,000

    6.

    Prevention and control of turkey rhinotracheitis (TRT): development of an inactivated vaccine

    $18,000

    7.

    Efficacy of a vaccine in control of Johne’s disease in cattle

    $17,940

    8.

    Potential effects of epizootic hemorrhagic disease on Iowa cattle

    $12,500

    9.

    Treatment and prevention of cryptosporidiosis of calves: screening of potential anti-cryptosporidial compounds in mice and calves

    $20,000

    10.

    Development of immunoprophylaxis for the prevention and control of bovine papillomatous digital dermatitis (hairy heel wart)

    $19,500

    11.

    Are granulocyte adapted Salmonella vaccines host species specific?

    $15,920

    12.

    Impact of sulfate, dissolved solids, iron, and other drinking water quality parameters to on-farm performance and health of dairy cattle in Iowa: implications for dairy industry

    $10,000

    13.

    Assessing the role of porcine circovirus I postweaning multisystemic wasting syndrome (PMWS) using a case-control study

    $18,000

    14.

    Bacteriological and serological survey of commercial chicken laying hens flocks for Ornithobacterium rhinotracheale

    $7,000

    15.

    Mycoplasma hyopneumoniae: comparison of immunological responses to vaccination and/or challenge in pigs with or without maternal antibodies

    $18,000

    16.

    Transformation of Mycoplasma bovis as an aid in identification of virulence factors

    $15,000

     

    Contingency Funds

    $10,713

     

    Total

    $277,573